Martin Pešta

机构：Charles University · ORCID：0000-0001-8187-0566

发表论文 149 篇 · 总被引 2532 次 · h-index 30

代表论文

• Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial (2021 · ˜The œLancet. Gastroenterology & hepatology · 被引 96)
• The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation (2024 · The EPMA Journal · 被引 61)
• Ischemic stroke of unclear aetiology: a case-by-case analysis and call for a multi-professional predictive, preventive and personalised approach (2022 · The EPMA Journal · 被引 59)
• Mitochondria-based holistic 3PM approach as the ‘game-changer’ for individualised rehabilitation—the proof-of-principle model by treated breast cancer survivors (2024 · The EPMA Journal · 被引 28)
• Ultrasensitive detection of BRAF mutations in circulating tumor DNA of non-metastatic melanoma (2021 · ESMO Open · 被引 26)
• Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer (2022 · Diagnostics · 被引 21)